scholarly journals Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Vida Gavric Lovrec ◽  
Darja Arko ◽  
Iztok Takac
Keyword(s):  
Cervical Cancer ◽  
Computer Program ◽  
Cancer Patients ◽  
General Hospital ◽  
Cancer Registry ◽  
Diagnostic Procedures ◽  
Medical Centre ◽  
Clinical Registry ◽  
The University

Abstract Background Clinical registries are designed to collect quality data about the care for cancer patients in order to improve it. They gather data that are generated during diagnosis and cancer treatment and also post-treatment follow-up. Analysis of collected data allows an improvement in the quality of patient care and a comparison with other health care providers. The aim of the present article is to describe the current version and practice of hospital-based cervical cancer registry in UKC Maribor. Materials and methods The first questionnaire for monitoring patients with cervical cancer was introduced at the Department of Gynecologic and Breast Oncology of the Maribor General Hospital in 1994. Since then, the principles for treating cervical cancer have been revised on several occasions. Therefore, based on our experience and new approaches to treatment, we have frequently amended the questionnaire content. It was redesigned into a form that is currently in use and transformed into a Cervix-Online computer program in 2014. Results Over the last 27 years, we have collected data on cervical cancer patients treated at the University Medical Centre Maribor and former Maribor General Hospital. The Cervix-Online computer program that was developed for this purpose enabled a rapid and reliable collection, processing and analysis of 116 different data of patients with cervical cancer, including general data, history, diagnostic procedures, histopathological examination results, treatment methods, and post-treatment follow-ups. Conclusions The hospital-based cervical cancer registry with Cervix-Online computer program enables the collection of data to enhance diagnosis and the treatment of cervical cancer patients, the organization of day-to-day service, as well as the comparison of our treatment results with national and international standards. Incomplete or incorrect data entry, however, might pose a limitation of the clinical registry, which depends on several healthcare professionals involved in the diagnostic procedures, treatment, and follow-up of cervical cancer patients.

Follow-up of cancer patients at the Colorectal Multidisciplinary Clinic: The University of the Philippines - Philippine General Hospital (UP-PGH) experience.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e18022-e18022
Author(s):  
Frederic Ivan Leong Ting ◽  
Danielle Benedict Leoncio Sacdalan ◽  
Josephine Anne Lucero Sacdalan ◽  
Dennis Lee Sacdalan
Keyword(s):  
Cancer Patients ◽  
General Hospital ◽  
The Philippines ◽  
Treatment Center ◽  
Design Strategies ◽  
Cross Sectional ◽  
Multidisciplinary Clinic ◽  
Rectal Cancers ◽  
The University

e18022 Background: The University of the Philippines - Philippine General Hospital (UP-PGH) Colorectal Multidisciplinary Team is composed of colorectal surgeons, radiation oncologists, and medical oncologists tasked with the care of patients with colon and rectal cancers in a multidisciplinary clinic. Patients that have been lost to follow-up after initial work-up and treatment return later with more advanced disease if at all they come back for treatment. This is a concern because cancers of the colon and rectum are potentially curable if addressed in a timely manner by patient and physician. Moreover, aggressive follow-up of potentially curable colon and rectal cancers has been shown to improve patient outcomes. Identifying factors that contribute to poor patient follow-up will allow the team to design strategies that will lead to more patients completing treatment. This study aimed to identify the different factors that influence follow-up among Filipino cancer patients presenting at the UP-PGH Colorectal multidisciplinary clinic. Methods: This is a 6 month prospective cross-sectional pilot study where a questionnaire was designed to evaluate patient views regarding factors that contribute to continued follow-up as well as factors associated with poor follow-up at the colorectal multidisciplinary clinic. Patients were allowed to state multiple factors as they see fit. Descriptive statistics were employed in the analysis of data. Results: Of the 97 responders, 39 (40%) patients identified belief in the effectiveness of the treatment and trust in their physicians, 33 (34%) stated adequacy of family support , and 31 (32%) noted affordability of treatment as factors contributing to patient follow-up. In contrast, 44 (45%) patients identified financial constraints, and 7 (7%) stated the far distance of their home to the treatment center as potential causes of poor follow-up. Other potential causes of poor follow-up identified were fear and anxiety about treatment, intolerable side-effects, and long lines at the clinic -all with 2 (2%) responses each. Conclusions: Healthcare decisions in the Philippines are affected by an interplay of factors. This study has identified belief in treatment efficacy, trust in their attending physician, financial factors, and clinic accessibility as influencing continued patient follow-up. Future endeavors may be directed towards these factors to improve follow-up and care at the colorectal multidisciplinary clinic.

scholarly journals Inquiry and computer program Onko-Online: 25 years of clinical registry for breast cancer at the University Medical Centre Maribor

2019 ◽  
Vol 53 (3) ◽  
pp. 348-356
Author(s):  
Darja Arko ◽  
Iztok Takac
Keyword(s):  
Breast Cancer ◽  
Computer Program ◽  
Cancer Patients ◽  
Health Care Providers ◽  
Cancer Registries ◽  
International Standards ◽  
Care Providers ◽  
Breast Cancer Patients ◽  
Clinical Registry

Abstract Background High-quality routine care data collected in the clinical registry play a significant role in improving the management of cancer patients. Clinical cancer registries record important data in the course of cancer diagnosis, treatment, follow-up and survival. Analyses of such comprehensive data pool make it possible to improve the quality of patients care and compare with other health care providers. Methods The first inquiry at the Department of Gynaecologic and Breast Oncology of the then General Hospital Maribor to follow breast cancer patients has been introduced in 1994. Based on our experience and new approaches in breast cancer treatment, the context of inquiry has been changed and extended to the present form, which served as a model for developing a relevant computer programme named Onko-Online in 2014. Results During the 25-year period, we collected data from about 3,600 breast cancer patients. The computer program Onko-Online allowed for quick and reliable collection, processing and analysis of 167 different data of breast cancer patients including general information, medical history, diagnostics, treatment, and follow-up. Conclusions The clinical registry for breast cancer Onko-Online provides data that help us to improve diagnostics and treatment of breast cancer patients, organize the daily practice and to compare the results of our treatment to the national and international standards. A limitation of the registry is the potentially incomplete or incorrect data input by different healthcare providers, involved in the treatment of breast cancer patients.

A Developing Anterior Mediastinal Mass In A Breast Cancer Patient : Thymic Hyperplasia

2021 ◽  
Vol 17 ◽  
Author(s):  
Nilgün Güldoğan ◽  
Aykut Soyder ◽  
Ebru Yılmaz ◽  
Aydan Arslan
Keyword(s):  
Breast Cancer ◽  
Cancer Patient ◽  
Cancer Patients ◽  
Mediastinal Mass ◽  
Diagnostic Procedures ◽  
Thymic Hyperplasia ◽  
Anterior Mediastinal Mass ◽  
Breast Cancer Patients ◽  
Thymus Hyperplasia

Introduction: True thymic hyperplasia following chemotherapy have been described mostly in children.There are a few cases of thymus hyperplasia have been reported in breast cancer patients . Diagnosis of this unusual entity is very crucial to pretend unnecessary surgery or interventional diagnostic procedures. Case Presentation: We report a case of thymus hyperplasia in a patient who was operated and treated with adjuvant chemotherapy for stage 2 breast cancer two years ago. In the follow-up CT scans an anterior mediastinal mass was noted. Radiologic evaluation and follow up revealed thymus enlargement. Discussion: Thymic hyperplasia following chemotherapy have been described in both children and adults, but occurs mostly in children and adolescents treated for lymphoma and several other types of tumors. Few cases are reported in literature describing thymus hyperplasia following chemotherapy in a breast cancer patient. Conclusion: Radiologists must be aware of this unusual finding in breast cancer patients treated with chemotherapy to guide the clinicians appropriately in order to avoid unnecessary surgical intervention, additional invasive diagnostic procedures, or chemotherapy.

A registry-based study of follow-up failures in the screening experience of cervical cancer patients

1998 ◽  
Vol 8 (3) ◽  
pp. 251-256 ◽  
Author(s):  
Amadori ◽  
Gentilini ◽  
Bucchi ◽  
Innocenti ◽  
Falcini ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Patients

What Kinds of Care Do New Cancer Patients Need? A One-Year Follow-Up Study of Patients Diagnosed in a Dutch General Hospital

1997 ◽  
Vol 30 (2) ◽  
pp. 131-145 ◽  
Author(s):  
Fred C.J. Stevens ◽  
Annemie M. Courtens ◽  
Luc P. De Witte ◽  
Harry F.J.M. Crebolder ◽  
Hans Philipsen
Keyword(s):  
Cancer Patients ◽  
General Hospital ◽  
Follow Up Study ◽  
One Year

scholarly journals Follow-Up Consultations for Cervical Cancer Patients in a Mexican Cancer Center. Comparison with NCCN Guidelines

2014 ◽  
Vol 15 (20) ◽  
pp. 8749-8752 ◽  
Author(s):  
Alberto Serrano-Olvera ◽  
Lucely Cetina ◽  
Jaime Coronel ◽  
Alfonso Duenas-Gonzalez
Keyword(s):  
Cervical Cancer ◽  
Cancer Patients ◽  
Cancer Center ◽  
Nccn Guidelines

Increasing risk for venous thromboembolism among hospitalized cancer patients

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 9009-9009
Author(s):  
A. A. Khorana ◽  
C. W. Francis ◽  
E. Culakova ◽  
N. M. Kuderer ◽  
G. H. Lyman
Keyword(s):  
Venous Thromboembolism ◽  
Cancer Patients ◽  
Diagnostic Procedures ◽  
Hematologic Malignancies ◽  
Medical Centers ◽  
Black Patients ◽  
Increased Risk ◽  
Anti Cancer ◽  
The University ◽  
Discharge Database

9009 Background: Venous thromboembolism (VTE) contributes to morbidity and mortality in cancer patients and is a frequent complication of anti-cancer therapy. We examined the frequency, risk factors and trends associated with VTE among hospitalized US cancer patients. Methods: We conducted a retrospective cohort study using the discharge database of the University Health System Consortium. This included all 1,824,316 hospitalizations of cancer patients between 1995 and 2003 at 133 United States medical centers. To avoid overestimation, only a single randomly chosen hospitalization was included for patients with multiple admissions. Results: Among 1,015,598 individual cancer patients, 34,357 (3.4%) were diagnosed with deep venous thrombosis and 11,515 with pulmonary embolism (PE) (1.1%) for an overall VTE rate of 4.1%. Subgroups of cancer patients with highest rates included Black ethnicity (5.1% per hospitalization) and those on chemotherapy (4.9%). Sites of cancer with the highest rates of VTE included pancreas (8.2%), kidney (5.7%), ovary (5.6%), lung (5.1%) and stomach (4.9%). Amongst hematologic malignancies, myeloma (5%), non-Hodgkin’s lymphoma (4.8%) and Hodgkin’s disease (4.6%) had the highest rates of VTE. The rate of VTE rose from 3.6% per hospitalization in 1995–96 to 4.6% in 2002–03, an increase of 28%, including a near-doubling of PE rates from 0.8% to 1.5% (P<0.0001). Among patients receiving chemotherapy, rates of VTE rose from 3.9% per hospitalization to 5.7%, an increase of 47% (P<0.0001). In contrast, patients undergoing surgery for breast, head and neck, pancreatic or spinal cancers, experienced no significant change in the rate of VTE. Use of diagnostic procedures for VTE also did not increase over the study period. Conclusions: The rate of VTE, including PE, among hospitalized cancer patients has increased significantly in recent years. Black patients, those on chemotherapy and those with certain types of cancer are disproportionately at increased risk. The rise in VTE does not appear to be attributable to an increased utilization of diagnostic procedures. Further efforts to increase thromboprophylaxis compliance during hospitalization are needed. No significant financial relationships to disclose.

Sign in / Sign up

Export Citation Format

Share Document